MEA Compression Therapy Market

MEA Compression Therapy Market Size (2024 to 2029)

The size of the Middle East and Africa compression therapy market is estimated to be growing at a healthy CAGR from 2024 to 2029.

The increase in the geriatric population is expected to accelerate the growth rate of the MEA compression therapy market during the forecast period. The proportion of the elderly population in many MEA countries is increasing rapidly. The elderly population is vulnerable to various chronic diseases. Compression therapy is a simple and effective way to improve venous support and increase the efficiency of blood flow in the lower extremities. Compression therapy is most often used in older people with chronic venous disease. In the United States, 84% of adults aged above 65 and older have at least one chronic disease. In addition, according to a United Nations study, the total number of people aged 80 and over is expected to increase from 153 million in 2019 to over 455 million in 2050. Hence, the increase in the geriatric population is expected to help the growth of the compression therapy market in MEA regions.

The increasing number of varicose veins, leg ulcers, and deep vein thrombosis is one of the significant factors that intensify the growth and demand of the compression therapy market. In addition, the increasing number of orthopedic procedures and collaborations, along with the increasing prevalence of sports injuries and accidents, also contributes to the growth of the MEA market during the forecast period. Moreover, the young accident-prone population and a large target population of patients also improve the market growth. In addition, the clinical evidence which has led to the adoption of Compression Therapy for the management of the target disease is also one of the significant factors driving the growth of the MEA Compression Therapy market.

Increased patient awareness of the benefits of compression therapy in managing target diseases, along with rapid technological advancements by manufacturers focusing on patient comfort, will further accelerate the expansion of the compression therapy market and offer significant growth opportunities for the market over the forecast period.

However, the lack of generally accepted standards for compression products, along with low patient adherence to compression garments, is predicted to hamper the growth rate of the compression therapy market in MEA. In contrast, the increased adoption of alternative therapies for treatments can challenge the growth of the MEA compression therapy market.

Impact of COVID-19 on the MEA compression therapy market:

Hospitals are affected by this pandemic because there is a clear shortage of health professionals in both developed and developing countries. The pandemic has also affected the field of orthopedics, as doctors cannot properly focus on regular patients as they are reassigned to treat COVID-19 patients. Consequently, orthopedic and trauma surgery has become a major challenge due to the unavailability of hospital staff and operating facilities. This is considered a major challenge for the growth of the MEA compression therapy market in the coming years.

This research report on the Middle East & Africa compression therapy market has been segmented and sub-segmented into the following categories:

By Product:

• Garments
  • Stockings
  • Bandages & Wraps
  • Other Garments
• Braces
• Pumps

By Technique:

• Static
• Dynamic

By Application:

• Varicose Vein Treatments
• Deep Vein Thrombosis Treatments
• Lymphedema Treatments
• Leg Ulcer Treatments
• Others

By Distribution Channel:

• Pharmacies & Retailers
• Hospitals & Clinics
• E-Commerce Platforms

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the Middle East region dominates the MEA compression therapy market due to the increasing geriatric population, increasing incidence of chronic venous disorders and obesity, and favorable government reimbursements in MEA. The Kingdom of Saudi Arabia is expected to develop at a significant growth rate during the forecast period 2024 to 2029 due to increased R&D investment by major players and constant initiatives to bring products to market at a comparatively lower than available in that particular region. In addition, other MEA regions such as UAE, Bahrain, and Qatar will have lucrative growth opportunities.

On the other hand, Africa will have the lowest share of the MEA compression therapy market due to the low per capita income, especially in the Northern African region.

KEY MARKET PLAYERS:

A few of the promising companies operating in the MEA compression therapy market profiled in this report are Medi GmbH & Co., Medtronic Plc, Julius Zorn GmbH, SIGVARIS, Hartmann AG, BSN Medical GmbH, ArjoHuntleigh, 3M Health Care, Spectrum Healthcare, Bio Compression Systems, Inc. and Gottfried Medical.